The Virtual Human Healthcare Model

A revolution in healthcare treatment and diagnosis may be imminent with a pan-European personalised healthcare project, the Virtual Physiological Human (VPH), a Network of Excellence (NoE). Funded with EUR 72 million under the Information and communication technologies Theme of the Seventh Framework Programme (FP7), the VPH aims to create an entire framework to deliver personalised patient computer models for the predictive healthcare of the future. Success could significantly limit the need for animal testing and patient drug trials.

A total of 13 institutions from 7 countries are involved in the VPH network. The partners hope that once their 'personalised healthcare framework' has been created, a wide range of doctors, scientists and researchers will be able to virtually investigate the human body as a single complex organism.

The VPH project will also create a constantly expanding knowledge database, which will be used to develop better patient diagnosis and treatment.

A postgraduate VPH training programme at the University of Nottingham in the UK will help scientists from diverse disciplines to carry out collaborative studies across the EU. Mathematicians and medical researchers who use mathematical modelling will work together to find solutions to complex biomedical problems, for example. Researchers from academia and industry will meet this week to present technical problems relating to regenerative medicine, particularly those involving epithelial cells in the skin, bladder, lungs, heart and breast.

It is hoped that the study groups will develop new theoretical illness models that may eventually form the basis for new research projects.

Dr Bindi Brook of the University of Nottingham's School of Mathematical Sciences said, "This study group is one of the prototypes for the sort of collaborative study which will be a key feature of our new VPH training programme. The course will allow postgraduates to train within the VPH network of European universities and, crucially, to access and contribute to a virtual VPH academy online."

The VPH project may revolutionise medical healthcare in the future. Employing emerging technologies such as genomics means that researchers in all areas can make use of enormous amounts of crucial and detailed physiological data. At the same time, advances in computer and information technology will make it easier for this information to be used to create genetic profiles of patients. It is hoped that over the next 10 years these advances will include treatments for both cancer and HIV/AIDS.

For further information, please visit:
http://www.vph-noe.eu

Copyright ©European Communities, 2009
Neither the Office for Official Publications of the European Communities, nor any person acting on its behalf, is responsible for the use, which might be made of the attached information. The attached information is drawn from the Community R&D Information Service (CORDIS). The CORDIS services are carried on the CORDIS Host in Luxembourg - http://cordis.europa.eu. Access to CORDIS is currently available free-of-charge.

Most Popular Now

Significant Disparities in Telemedicine …

After "COVID-19," the term that most people will remember best from 2020 is likely to be "social distancing." While it most commonly applied to social gatherings with family and friends...

Model Used to Evaluate Lockdowns was Fla…

In a recent study, researchers from Imperial College London developed a model to assess the effect of different measures used to curb the spread of the coronavirus. However, the model...

Using Artificial Intelligence to Find Ne…

Scientists have developed a machine-learning method that crunches massive amounts of data to help determine which existing medications could improve outcomes in diseases for which they are not prescribed. The intent...

FDA Releases Artificial Intelligence / M…

Today, the U.S. Food and Drug Administration released the agency's first Artificial Intelligence/Machine Learning (AI/ML)-Based Software as a Medical Device (SaMD) Action Plan. This action plan describes a multi-pronged approach...

New Virtual Screening Strategy Identifie…

A novel computational drug screening strategy combined with lab experiments suggest that pralatrexate, a chemotherapy medication originally developed to treat lymphoma, could potentially be repurposed to treat COVID-19. Haiping Zhang...

CliniSys Launches Laboratory Information…

CliniSys has launched a new laboratory information management system for genomic laboratories in the UK. The company has brought GLIMS Genomics to the UK from Europe, where it is being...

The Institute of Healthcare Management C…

The Institute of Healthcare Management has called for honest and open communication about NHS capacity after a snapshot survey revealed the scale of sickness absence across the service. The UK's leading...

One in Four Doctors Attacked, Harassed o…

While many physicians benefit from social media by networking with potential collaborators or interfacing with patients, a new study from Northwestern University and the University of Chicago found many physicians...

First NHS Trust and Sectra Achieve Rapid…

A new region-wide approach to analysing x-rays, MRI scans, CT scans, mammography, and an entire range of crucial diagnostic images, has started to become reality, now that The Pennine Acute...

Abbott to Launch the NeuroSphere™ myPath…

Abbott (NYSE: ABT) today announced the upcoming launch of NeuroSphere™ myPath™, a digital health app designed to track and report on patient perceived pain relief and general well-being associated with...

Bayer Transforms Pharma Business through…

At its virtual Pharma Media Day, Bayer presented exciting progress in transforming its pharmaceutical business with breakthrough innovation in healthcare that will significantly help patients suffering from conditions that are...